Position in PFE
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$355,180
-$59,000 QoQ
Shares Held
14,750
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,999
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ABNER HERRMAN & BROCK LLC holds $83,857,322 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,138 | $32,550,134 | |
| 2 | MRK |
Merck & Co., Inc.
|
202,424 | $26,011,484 | |
| 3 | JNJ |
Johnson & Johnson
|
79,588 | $20,212,964 | |
| 4 | AMGN |
Amgen Inc
|
8,418 | $3,048,326 | |
| 5 | ABBV |
AbbVie Inc.
|
2,515 | $632,874 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,000 | $576,200 | |
| 7 | NVS |
Novartis AG
|
3,000 | $470,160 | |
| 8 | PFE |
Pfizer Inc
This page
|
14,750 | $355,180 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $355,180 | 14,750 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $414,180 | 14,750 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $373,475 | 14,999 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $375,830 | 14,750 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $357,540 | 14,750 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $373,765 | 14,750 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $391,317 | 14,750 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $397,925 | 13,750 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $390,321 | 13,950 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $387,112 | 13,950 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $368,915 | 12,814 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $384,407 | 11,589 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $438,472 | 11,954 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $481,970 | 11,813 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $605,298 | 11,813 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $516,936 | 11,813 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $619,355 | 11,813 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $479,752 | 9,267 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $559,262 | 9,471 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $367,606 | 8,547 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $338,734 | 8,650 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $1,705,527 | 47,075 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $3,712,730 | 100,862 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $3,715,174 | 101,231 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $5,643,666 | 172,589 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $1,965,219 | 60,209 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||